Moreover, in AD patients, PTK2B appears to be associated with hippocampal sclerosis (Beecham et al., 2014), disease progression (Wang et al., 2015), and cognitive decline (Nettiksimmons et al., 2016). This evidence concerns the gene PTK2B and Alzheimer disease.